Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lantu Biopharma

Clinical trials sponsored by Lantu Biopharma, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Gene therapy could free Beta-Thalassemia patients from lifelong transfusions Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 2

Gene therapy for SMA tested in real-world settings of poorer nations

Disease control Recruiting now

This study is testing a gene therapy called vesemnogene lantuparvovec for spinal muscular atrophy (SMA) in low- and middle-income countries. Researchers will track safety and whether children reach motor milestones like sitting or walking. The trial involves 15 participants and a…

Phase 3 • Sponsor: Lantu Biopharma • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC